HUM logo

Humana Inc. Stock Price

NYSE:HUM Community·US$37.0b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 123 Fair Values set on narratives written by author

HUM Share Price Performance

US$301.69
75.08 (33.13%)
US$210.46
Fair Value
US$301.69
75.08 (33.13%)
43.3% overvalued intrinsic discount
US$210.46
Fair Value
Price US$301.69
AnalystConsensusTarget US$210.46
yiannisz US$212.87
AnalystHighTarget US$371.06

HUM Community Narratives

·
Fair Value US$210.46 43.3% overvalued intrinsic discount

HUM: Medicare Advantage Stars And ACA Premiums Will Shape Balanced Near-Term Outlook

0users have liked this narrative
0users have commented on this narrative
63users have followed this narrative
Fair Value
·
Fair Value US$212.87 41.7% overvalued intrinsic discount

Humana Faces Rising Medicare Scrutiny as Compliance Rules Tighten

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$371.06 18.7% undervalued intrinsic discount

Aging Population And Tech Will Shape Long-Term Medicare Care

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$212.87
41.7% overvalued intrinsic discount
Fair Value
Revenue
8.7% p.a.
Profit Margin
1.02%
Future PE
18.03x
Price in 2031
US$298.25
US$371.06
18.7% undervalued intrinsic discount
Revenue
14.42% p.a.
Profit Margin
1.85%
Future PE
14.29x
Price in 2029
US$455.51
US$210.46
43.3% overvalued intrinsic discount
Revenue
12.42% p.a.
Profit Margin
1.68%
Future PE
9.96x
Price in 2029
US$257.01
US$146
106.6% overvalued intrinsic discount
Revenue
9.1% p.a.
Profit Margin
1.65%
Future PE
7.74x
Price in 2029
US$178.32

Trending Discussion

Updated Narratives

HUM logo

Humana Faces Rising Medicare Scrutiny as Compliance Rules Tighten

Fair Value: US$212.87 41.7% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HUM logo

HUM: Medicare Advantage Margin Recovery Will Support Future Multiple Repricing

Fair Value: US$371.06 18.7% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
HUM logo

HUM: Medicare Advantage Margin Recovery Will Offset Regulatory And Cost Uncertainty

Fair Value: US$210.46 43.3% overvalued intrinsic discount
63 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Adequate balance sheet average dividend payer.

2 Risks
2 Rewards

Humana Inc. Key Details

US$137.2b

Revenue

US$118.0b

Cost of Revenue

US$19.2b

Gross Profit

US$18.1b

Other Expenses

US$1.1b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 29, 2026
9.41
14.01%
0.82%
77.1%
View Full Analysis

About HUM

Founded
1961
Employees
67060
CEO
James Rechtin
WebsiteView website
www.humana.com

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Recent HUM News & Updates

Narrative Update May 25

HUM: Medicare Advantage Margin Recovery Will Support Future Multiple Repricing

Humana's updated analyst price target of about $371, up from roughly $322, reflects analysts' focus on stabilizing managed care trends, expectations around Medicare Advantage margin recovery, and a shift to a slightly higher discount rate and profit margin in the underlying assumptions. Analyst Commentary Recent Street research on Humana centers on how quickly Medicare Advantage margins might stabilize, how medical loss ratios track against company targets, and what that could mean for valuation as managed care trends settle.
Seeking Alpha May 18

Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)

Summary Humana Inc. is upgraded to Buy as shares rebound from a >65% decline, supported by improved CMS rate decisions and activist investor involvement. Despite 2026 EPS guidance below Q1 levels, HUM targets a sustainable 3%+ Medicare Advantage margin and long-term earnings growth by 2028. Recent Q1 results exceeded revenue and adjusted EPS expectations, with a favorable medical benefit ratio and affirmed 25% MA membership growth for 2026. Activist pressure and management’s focus on pricing, benefit adjustments, and operational discipline position HUM for a potential return to >$450/share by 2028. Read the full article on Seeking Alpha

Recent updates

No updates